Brookstone Capital

Brookline Capital Markets is a boutique investment bank that specializes in the life sciences, healthcare, and technology sectors. As a division of Arcadia Securities, the firm provides a comprehensive suite of services including equity research, investment banking, and capital markets advisory, with a particular focus on emerging growth biotechnology companies. Brookline is well-regarded for its expertise in structuring initial public offerings (IPOs), follow-on offerings, and private placements, as well as its significant involvement in Special Purpose Acquisition Companies (SPACs) within the biopharma space. The firm's research team offers deep technical and clinical analysis, making it a key resource for institutional investors navigating the healthcare sector.